Life-threatening acute pancreatitis associated with interferon beta-1a treatment in multiple sclerosis.
Midgard
Rune
R
Department of Neurology, Molde Hospital, Parkvn 84, Molde, Norway. rmidgard@online.no
Ertresvåg
Kåre
K
Trondsen
Erik
E
Spigset
Olav
O
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000009:adverse effects; D000681:Amylases / Q000097:blood; D013505:Digestive System Surgical Procedures; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D010179:Pancreas / Q000187:drug effects* / Q000503:physiopathology / Q000601:surgery; D019283:Pancreatitis, Acute Necrotizing / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D055502:Secondary Prevention; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000681:Amylases; D000068556:Interferon beta-1a